Q2 2023 Holdings
Filed 2023-08-14 | 55 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $299.5M | 1,381,149 | 19.6% |
| Natera Inc(NTRA) | COM | 632307104 | $150.9M | 3,100,560 | 9.9% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $121.5M | 1,697,517 | 8.0% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $68.8M | 201,182 | 4.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $67.3M | 754,032 | 4.4% |
| Aerovate Therapeutics Inc | COM | 008064107 | $64.5M | 3,758,686 | 4.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $60.9M | 527,373 | 4.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $55.6M | 3,467,156 | 3.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $51.1M | 145,300 | 3.3% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $48.9M | 2,560,738 | 3.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $47.6M | 370,720 | 3.1% |
| Idexx Laboratories Inc(IDXX) | COM | 45168D104 | $35.5M | 70,674 | 2.3% |
| Immatics NV(IMTX) | SHS | N44445109 | $35.1M | 3,041,487 | 2.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $33.1M | 1,582,291 | 2.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $32.9M | 608,861 | 2.2% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $32.9M | 322,471 | 2.2% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $27.5M | 843,228 | 1.8% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $25.9M | 998,283 | 1.7% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $23.4M | 828,005 | 1.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $20.4M | 3,655,308 | 1.3% |
| Geron Corp(GERN) | COM | 374163103 | $17.4M | 5,429,155 | 1.1% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $16.5M | 362,200 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $15.6M | 664,746 | 1.0% |
| ImmunoGen Inc(IMGNEUR) | COM | 45253H101 | $15.6M | 827,318 | 1.0% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $15.6M | 39,921 | 1.0% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $14.9M | 2,194,278 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $13.9M | 520,377 | 0.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $12.9M | 179,242 | 0.8% |
| Vir Biotechnology Inc(VIR) | COM | 92764N102 | $12.0M | 488,117 | 0.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $10.6M | 260,443 | 0.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $10.5M | 962,619 | 0.7% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $9.6M | 3,083,712 | 0.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $8.1M | 348,889 | 0.5% |
| Agenus Inc(AGENEUR) | COM | 00847G705 | $7.9M | 4,909,132 | 0.5% |
| Vir Biotechnology Inc(VIR)Put | COM | 92764N102 | $7.4M | 300,000 | 0.5% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $6.7M | 197,758 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.0M | 441,048 | 0.3% |
| Nextcure Inc | COM | 65343E108 | $4.8M | 2,671,856 | 0.3% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $4.4M | 5,599,999 | 0.3% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $3.5M | 2,754,437 | 0.2% |
| Marinus Pharmaceuticals Inc(MRNS*)Call | COM | 56854Q200 | $2.2M | 200,000 | 0.1% |
| Nucana PLC | COMMON SHARES | GB00BYWYV | $1.9M | 2,400,000 | 0.1% |
| FibroGen Inc(FGENEUR)Put | COM | 31572Q808 | $1.8M | 650,000 | 0.1% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $1.7M | 637,567 | 0.1% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $717.5K | 142,635 | 0.0% |
| FibroGen Inc(FGENEUR)Call | COM | 31572Q808 | $675.0K | 250,000 | 0.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $546.9K | 117,099 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $307.5K | 96,248 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $272.3K | 62,465 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $247.2K | 574,972 | 0.0% |